User Fee Talks On Schedule And Making Progress, Industry Says
This article was originally published in The Gray Sheet
Executive Summary
Despite FDA warnings that time is running out for an agreement to be reached with industry on a user fee reauthorization plan, device industry leaders say the two sides have made “good progress” toward reaching a pact.